Substrate Specificity for Human Histidine Methyltransferase SETD3

Jordi C. J. Hintzen, Huida Ma, Hao Deng, Apolonia Witecka, Steffen B. Andersen, Jakub Drożak, Hong Guo, Ping Qian, Haitao Li, Jasmin MecinovićbioRxiv 2021 · DOI

TL;DR

This paper investigates the substrate specificity of human histidine methyltransferase SETD3, revealing a broader enzymatic scope than previously understood. By combining synthetic, biochemical, structural, and computational approaches, the researchers demonstrate that SETD3 can methylate not only histidine but also various histidine mimics, offering crucial insights into its catalytic mechanism and potential for broader biological roles.

What Problem Does This Paper Address?

Histidine methylation is a crucial post-translational modification (PTM) that plays significant roles in various biological processes, including cell structure and disease. SETD3 was previously identified as the enzyme responsible for methylating histidine 73 (His73) in β-actin, a key component of the cytoskeleton. However, the full substrate specificity and catalytic versatility of SETD3 remained largely unexplored. This paper aims to address this gap by systematically investigating how SETD3 interacts with and modifies a diverse panel of histidine analogs, thereby deepening our understanding of its enzymatic mechanism and potential biological functions beyond β-actin His73.

Methods

The study employs a multi-faceted approach:

  • Synthetic Chemistry: A diverse panel of β-actin peptides incorporating various histidine analogs was synthesized using automated microwave-assisted solid-phase peptide synthesis (SPPS). This allowed for precise structural modifications to probe SETD3's recognition and catalytic capabilities.
  • Enzymatic Assays (MALDI-TOF MS): Methylation reactions were performed using recombinant human SETD3 and S-adenosylmethionine (SAM) as the methyl donor. The extent of methylation was quantified using Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) to identify which analogs were substrates and to what degree.
  • Biostructural Studies (X-ray Crystallography): Crystal structures of SETD3 in complex with selected histidine analog-containing β-actin peptides and SAH (a byproduct of methylation) were determined. This provided atomic-level insights into how SETD3 binds to its substrates and the structural basis for its specificity.
  • Computational Simulations (QM/MM MD and Free Energy Simulations): Quantum Mechanics/Molecular Mechanics (QM/MM) molecular dynamics simulations were used to model the transition states of methylation reactions for various substrates. Free energy profiles (Potential of Mean Force, PMF) were calculated to determine the energy barriers for methyl transfer, offering a deeper understanding of the catalytic mechanism and energetic favorability of different substrates.
  • Isothermal Titration Calorimetry (ITC): Binding affinities of SETD3 to different peptide substrates were measured using ITC to quantify the strength of interaction and complement kinetic data.

Datasets

Not explicitly discussed as "datasets" in the traditional machine learning sense. The study utilizes:

  • Synthetic β-actin peptides: A library of 16-mer β-actin peptides (residues 66-81) with engineered histidine analogs at position 73.
  • Recombinant human SETD3: Purified enzyme used for all enzymatic assays.
  • S-adenosylmethionine (SAM): The methyl donor co-substrate.
  • SAH (S-adenosylhomocysteine) and SFG (sinefungin): Used in binding studies.
  • Existing crystal structures: Used as starting points for computational modeling.

Key Insights and Ideas

  • Broader Substrate Scope: SETD3 is not strictly limited to histidine; it can efficiently methylate several structurally diverse histidine mimics, suggesting a more flexible active site than initially presumed.
  • "Head-to-Head" Engagement: Structural analyses reveal that SETD3 employs a "head-to-head" binding mode for its substrates, where the methyl acceptor group is positioned in close proximity to the methyl donor (SAM). This geometry-sensitive interaction is key to its specificity.
  • Importance of N³ Nitrogen: The N³ nitrogen of histidine (or its equivalent in analogs) is the primary site of methylation, consistent with previous findings. The presence of a hydrogen atom on this nitrogen appears crucial for optimal binding and catalysis.
  • Steric and Electronic Factors: The size and electronic properties of the side chain significantly influence SETD3's catalytic efficiency. For instance, the bulkier side chain of ornithine, while accommodated, leads to weaker binding compared to histidine.
  • pH Dependence: The methylation activity of SETD3 can be influenced by pH, particularly for analogs with different pKa values, highlighting the importance of the protonation state of the substrate.
  • Computational Models Validate Experiments: QM/MM simulations successfully reproduced experimental kinetic data, providing a powerful tool for understanding the energetic barriers and mechanistic details of SETD3-catalyzed methylation.

Key Results

  • Histidine Analogs as Substrates: Several histidine analogs, including β-triazolylalanine (βTriaA73) and 4-pyridinylalanine (4PyrAla73), were found to be excellent SETD3 substrates, with catalytic efficiencies comparable to or slightly lower than native histidine.
  • Good but Poorer Substrates: N¹-methylhistidine (N¹-Me-His73), 3-pyridinylalanine (3PyrAla73), and ornithine (Orn73) were also methylated but showed significantly reduced catalytic efficiency.
  • Limited Methylation of Lysine Analogs: While some lysine analogs (Dab, Orn) showed minor methylation, they were generally poor substrates compared to histidine and its mimics.
  • Low Binding Affinity for Some Analogs: ITC studies revealed varying binding affinities, with some analogs showing significantly weaker interactions with SETD3 than the native His73 peptide.
  • Structural Basis for Specificity: Crystal structures revealed how SETD3 accommodates different side chains, highlighting steric clashes and favorable interactions that dictate substrate preference.
  • Energetic Barriers: QM/MM simulations showed that SETD3-catalyzed methylation of histidine and βTriaA73 had the lowest free energy barriers, correlating with their higher catalytic efficiency.

Limitations and Future Work

  • Limited Scope of Lysine Analogs: While some lysine analogs were tested, a more comprehensive exploration of lysine's role and potential modifications might be beneficial.
  • In Vitro vs. In Vivo: The study primarily uses synthetic peptides. Future work could investigate SETD3's activity on full-length proteins and in a cellular context to understand in vivo relevance.
  • Exploring Other PTMs: While this paper focuses on methylation, SETD3's potential involvement in other histidine modifications or its interaction with other PTMs could be explored.
  • Therapeutic Potential: The identification of SETD3's substrate specificity opens avenues for developing specific inhibitors or activators for therapeutic purposes, particularly in diseases where histidine methylation plays a role.
  • Broader Biological Roles: Further research is needed to fully elucidate the diverse biological roles of SETD3 and its substrates beyond β-actin methylation.

Summary updated

Abstract

Histidine methyltransferase SETD3 plays an important role in human biology and diseases. Previously, we showed that SETD3 catalyzes N 3 -methylation of histidine 73 in β-actin (Kwiatkowski et al., 2018). Here we report integrated synthetic, biocatalytic, biostructural and computational analyses on human SETD3-catalyzed methylation of β-actin peptides possessing histidine and its structurally and chemically diverse mimics. Our enzyme assays supported by biostructural analyses demonstrate that SETD3 has a broader substrate scope beyond histidine, including N-nucleophiles on the aromatic and aliphatic side chains. Quantum mechanical/molecular mechanical (QM/MM) molecular dynamics and free-energy simulations provide insight into binding geometries and the free energy barrier for the enzymatic methyl transfer to histidine mimics, further supporting experimental data that histidine is the superior SETD3 substrate over its analogs. This work demonstrates that human SETD3 has a potential to catalyze efficient methylation of several histidine mimics, overall providing mechanistic, biocatalytic and functional insight into β-actin histidine methylation by SETD3.
BibTeX
@misc{hintzen2021substrate,
  author = {Jordi C. J. Hintzen and Huida Ma and Hao Deng and Apolonia Witecka and Steffen B. Andersen and Jakub Drożak and Hong Guo and Ping Qian and Haitao Li and Jasmin Mecinović},
  title = {{Substrate Specificity for Human Histidine Methyltransferase SETD3}},
  year = {2021},
  doi = {10.1101/2021.12.30.474520},
  howpublished = {bioRxiv},
}
Figure